SOD2 and gastric cancer: The diagnostic performance of exosomal lncRNA-GC1, assessed in both the combined test set and the validation set, demonstrated a sensitivity of 0.8824, a specificity of 0.8229, and an AUC of 0.8905 (95% CI: 0.8371–0.9438) for detecting early-stage GC.